Inhaled anticholinergic drug therapy and the risk of acute urinary retention in chronic obstructive pulmonary disease: a population-based study.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Archives of Internal Medicine

• Publication date

  2011-05-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/archinternmed.2011.170PMID 21606096
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhaled anticholinergic drugs and risk of acute urinary retention

  2011cited by this paper
• Trends in chronic obstructive pulmonary disease prevalence, incidence, and mortality in ontario, Canada, 1996 to 2007: a population-based study.

  2010influential reference
• UPLIFT Study: the effects of long-term therapy with inhaled tiotropium in chronic obstructive pulmonary disease

  2009cited by this paper
• Tiotropium in chronic obstructive pulmonary disease.

  2009cited by this paper
• Identifying Individuals with Physcian Diagnosed COPD in Health Administrative Databases

  2009cited by this paper
• Tiotropium in chronic obstructive pulmonary disease.

  2009cited by this paper
• Tiotropium in chronic obstructive pulmonary disease.

  2009cited by this paper
• A 4-year trial of tiotropium in chronic obstructive pulmonary disease.

  2008cited by this paper
• Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease--2008 update--highlights for primary care.

  2008cited by this paper
• Tiotropium does not affect lower urinary tract functions in COPD patients with benign prostatic hyperplasia.

  2008cited by this paper
• Drug-Induced Urinary Retention

  2008cited by this paper
• Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2008 update - highlights for primary care.

  2008cited by this paper
• Mortality in men admitted to hospital with acute urinary retention: database analysis

  2007influential reference
• Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update.

  2007cited by this paper
• Incidence of primary and recurrent acute urinary retention between 1998 and 2003 in England.

  2006cited by this paper
• Pooled clinical trial analysis of tiotropium safety.

  2006cited by this paper
• The Anticholinergic Drug Scale as a Measure of Drug‐Related Anticholinergic Burden: Associations With Serum Anticholinergic Activity

  2006cited by this paper
• Nonsteroidal anti-inflammatory drugs and increased risk of acute urinary retention.

  2005cited by this paper
• Acute urinary retention: risks and management.

  2005cited by this paper
• Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper.

  2004cited by this paper
• Coding accuracy of administrative drug claims in the Ontario Drug Benefit database.

  2003influential reference
• Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm.

  2002cited by this paper
• Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients.

  2001cited by this paper
• A randomised controlled comparison of tiotropium nd ipratropium in the treatment of chronic obstructive pulmonary disease. The Dutch Tiotropium Study Group.

  2000cited by this paper
• A randomised controlled comparison of tiotropium and ipratropium in the treatment of chronic obstructive pulmonary disease

  2000cited by this paper
• Expressing the magnitude of adverse effects in case-control studies: “the number of patients needed to be treated for one additional patient to be harmed”

  2000cited by this paper
• Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.

  1995influential reference
• Muscarinic receptor subtypes in airways.

  1993cited by this paper
• Muscarinic receptor subtypes in airways.

  1993cited by this paper
• Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

  1992cited by this paper
• Urinary Retention Associated with Ipratropium Bromide

  1991cited by this paper
• Acute urinary retention in women: a prospective study of 18 consecutive cases.

  1987cited by this paper

• ХРОНИЧЕСКАЯ ОБСТРУКТИВНАЯ БОЛЕЗНЬ ЛЕГКИХ: ПРИНЦИПЫ ТЕРАПИИ ПОЖИЛЫХ ПАЦИЕНТОВ

  2025cites this paper
• Neural network analysis of the contribution of psychotropic prescription sequences to the risk of non-psychiatric adverse events in bipolar and schizophrenia spectrum disorders

  2025cites this paper
• Beneficial effects of anticholinesterases: Reducing the anticholinergic load, the missing link of the story?

  2025cites this paper
• Update on the pharmacological treatment of chronic obstructive pulmonary disease

  2024cites this paper
• The efficacy and safety of additional treatment with short-acting muscarinic antagonist combined with long-acting beta-2 agonist in stable patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis

  2023cites this paper
• Ensifentrine, a Novel Phosphodiesterase 3 and 4 Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease: Randomized, Double-Blind, Placebo-controlled, Multicenter Phase III Trials (the ENHANCE Trials)

  2023cites this paper
• Pharmacotherapies in Older Adults with COPD: Challenges and Opportunities

  2023cites this paper
• Diagnostic and therapeutic approaches for elderly asthma patients: the importance of multidisciplinary and multidimensional management

  2023cites this paper
• Prise en charge anesthésique périopératoire du patient BPCO

  2022cites this paper
• Medication changes and potentially inappropriate prescribing in older patients with significant polypharmacy

  2022cites this paper
• [Translated article] Spanish COPD Guideline (GesEPOC) Update: Comorbidities, Self-Management and Palliative Care.

  2022cites this paper
• Spanish COPD Guideline (GesEPOC) Update: Comorbidities, Self-Management and Palliative Care.

  2021cites this paper
• Predictors of postoperative urinary retention following pulmonary resection.

  2021cites this paper
• A practical introduction to conducting and using case‐control studies

  2021influential citation
• Redundant medication use during acute exacerbation of chronic obstructive pulmonary disease in hospitalized patients

  2020cites this paper
• COPD: A Disease of Aging

  2019cites this paper
• Acute Urinary Retention

  2019cites this paper
• Medication Appropriateness in Vulnerable Older Adults: Healthy Skepticism of Appropriate Polypharmacy

  2019cites this paper
• Community Assessment of COPD Health Care (COACH) study: a clinical audit on primary care performance variability in COPD care

  2018cites this paper
• Long-term safety of tiotropium/olodaterol Respimat® in patients with moderate-to-very severe COPD and renal impairment in the TONADO® studies

  2018cites this paper
• Polypharmacy, chronic kidney disease, and benign prostatic hyperplasia in patients with chronic obstructive pulmonary disease newly treated with long-acting anticholinergics.

  2017cites this paper
• Inhaled Long-acting Anticholinergics and Urinary Tract Infection in Individuals with COPD

  2017cites this paper
• Holmium Laser Enucleation of the Prostate in Patients Requiring Anticoagulation

  2017cites this paper
• Safety Considerations with Dual Bronchodilator Therapy in COPD: An Update

  2016cites this paper
• Factors responsible for poor sleep quality in patients with chronic obstructive pulmonary disease

  2016cites this paper
• The safety of anticholinergic bronchodilators for the treatment of chronic obstructive pulmonary disease

  2015cites this paper
• Prescription rate of medications potentially contributing to lower urinary tract symptoms and detection of adverse reactions by prescription sequence symmetry analysis

  2015cites this paper
• Comment on: Wollmer P, Engström G. Fixed ratio or lower limit of normal (LLN) as cut-off value for FEV1/VC: An outcome study. Respiratory Medicine (2013) 107, 1460-1462.: Fixed ratio or lower limit of normal (LLN) as cut-off value for FEV1/VC.

  2015cites this paper
• Treating COPD in Older and Oldest Old Patients.

  2015cites this paper
• Chapter 16 - Drugs that act on the respiratory tract

  2014cites this paper
• Current drug treatment, chronic and acute.

  2014cites this paper
• Differential pharmacology and clinical utility of emerging combination treatments in the management of COPD – role of umeclidinium/vilanterol

  2014cites this paper
• Effect of Oxygen-driven Nebulization at Different Oxygen Flows in Acute Exacerbation of Chronic Obstructive Pulmonary Disease Patients

  2014cites this paper
• Inhaled Anticholinergics and Risk for Acute Urinary Retention: A Case-Crossover and Case-Time-Control Study.

  2014cites this paper
• Pharmacological Treatment: an Update

  2014cites this paper
• Bromek Aklidyny w Leczeniu POChP—Opinia Interdyscyplinarnej Grupy Roboczej

  2014cites this paper
• Anestesia y enfermedad pulmonar obstructiva crónica

  2014cites this paper
• Anestesia e broncopneumopatia cronica ostruttiva

  2014cites this paper
• Use of databases for clinical research

  2014cites this paper
• Anesthésie et bronchopneumopathie chronique obstructive

  2014cites this paper
• Risk of acute urinary retention associated with inhaled anticholinergics in patients with chronic obstructive lung disease: systematic review

  2013influential citation
• The Adjunctive Effect of Nebulized Furosemide in COPD Exacerbation: A Randomized Controlled Clinical Trial

  2013cites this paper
• Obstructive Pulmonary Disease Exacerbation: A Randomized Controlled Clinical Trial

  2013cites this paper
• WOC nurse consult: difficulty voiding.

  2013cites this paper
• The incidence of acute urinary retention secondary to BPH is increasing among California men

  2013cites this paper
• Long-acting anticholinergics in the treatment of asthma

  2013cites this paper
• Re: Inhaled anticholinergic agents and acute urinary retention in men with lower urinary tract symptoms or benign prostatic hyperplasia.

  2013cites this paper
• Respiratory impairment and the aging lung: a novel paradigm for assessing pulmonary function.

  2012cites this paper
• Risks associated with tiotropium in chronic obstructive pulmonary disease: overview of the evidence to date

  2012influential citation
• Aclidinium bromide, a novel long-acting muscarinic antagonist for COPD with improved preclinical renal and urinary safety profile.

  2012cites this paper
• Caring for the older person with chronic obstructive pulmonary disease.

  2012cites this paper
• Reconsideration of key articles regarding medication-related problems in older adults from 2011.

  2012cites this paper
• Concomitant Use of Ipratropium and Tiotropium in Chronic Obstructive Pulmonary Disease

  2012cites this paper
• Pharmakotherapie im Alter aus internistisch-pneumologischer Sicht

  2012cites this paper
• Anticholinergic burden: clinical implications for seniors and strategies for clinicians.

  2012cites this paper
• Aclidinium bromide for the treatment of chronic obstructive pulmonary disease

  2012cites this paper
• Drugs that act on the respiratory tract

  2012cites this paper
• Respiratory impairment and COPD hospitalisation in older persons: a competing risk analysis

  2012cites this paper
• Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials

  2012cites this paper
• Inhaled Anticholinergic Agents and Acute Urinary Retention in Men with Lower Urinary Tract Symptoms or Benign Prostatic Hyperplasia

  2012cites this paper
• Pharmacology and Therapeutics of Bronchodilators

  2012cites this paper
• Special featureGeriatric Pharmacotherapy Updates

  2011cites this paper
• Inhaled anticholinergic medications in older men with chronic obstructive pulmonary disorder are associated with increased odds of acute urinary retention

  2011cites this paper
• Comorbidities of chronic obstructive pulmonary disease

  2011cites this paper
• Practical management problems of stable chronic obstructive pulmonary disease in the elderly

  2011cites this paper